VanEck Biotech ETF Rating $257.79 +0.56 (+0.22%) Closing price 11/11/2026 03:58 PM EasternExtended Trading$257.79 0.00 (0.00%) As of 11/11/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatingsShort Interest VanEck Biotech ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.64Holdings in BBH have an aggregate rating of Moderate Buy based on 590 analyst ratings issued in the past year covering 25 companies (99.9% of the portfolio).BBH Aggregate Price Target$257.79High Prediction$257.79Average Prediction$257.79Low Prediction$257.79Holdings in BBH have an aggregate price target of $257.79 and a range of $257.79 to $257.79 covering 25 companies (99.9% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBH Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings16.61%AMGNAmgen$468.11+0.6%Hold$422.76 -9.7%334.4461 of 5 starsTrending News14.22%GILDGilead Sciences$169.73-0.7%Moderate Buy$170.15 0.2%293.3069 of 5 starsTrending NewsInsider Trade8.29%VRTXVertex Pharmaceuticals$547.03-0.2%Moderate Buy$596.44 9.0%283.031 of 5 starsAnalyst Downgrade7.71%MRNAModerna$248.69-0.9%Hold$113.75 -54.3%251.7183 of 5 starsTrending NewsEarnings ReportAnalyst ForecastAnalyst Revision7.47%REGNRegeneron Pharmaceuticals$959.41+4.7%Moderate Buy$898.97 -6.3%313.8907 of 5 starsTrending News4.35%IQVIQVIA$274.73-0.2%Moderate Buy$294.21 7.1%213.6623 of 5 starsPositive News4.28%ARGXargenex$977.58+0.6%Moderate Buy$1,158.76 18.5%284.2205 of 5 stars3.81%RVMDRevolution Medicines$180.70-6.4%Moderate Buy$263.15 45.6%243.4552 of 5 starsTrending NewsAnalyst RevisionGap Up3.57%NTRANatera$319.82+2.5%Moderate Buy$394.31 23.3%233.2922 of 5 starsEarnings ReportAnalyst ForecastGap Up3.04%ILMNIllumina$212.93-0.9%Hold$244.24 14.7%192.8862 of 5 starsTrending NewsGap Up2.96%ONCBeOne Medicines$419.98-0.9%Buy$436.92 4.0%183.7241 of 5 starsEarnings ReportInsider Trade2.90%BIIBBiogen$253.40+0.1%Moderate Buy$254.41 0.4%333.7428 of 5 starsPositive NewsAnalyst Forecast2.45%GHGuardant Health$154.78-0.4%Moderate Buy$190.88 23.3%263.6437 of 5 starsTrending NewsEarnings ReportAnalyst Forecast2.24%UTHRUnited Therapeutics$595.66+1.2%Moderate Buy$676.40 13.6%164.5054 of 5 starsTrending NewsAnalyst ForecastInsider TradeAnalyst Revision2.12%INCYIncyte$122.27+1.6%Hold$132.86 8.7%252.8597 of 5 starsInsider Trade2.04%INSMInsmed$120.75+1.1%Moderate Buy$196.52 62.8%263.5741 of 5 stars1.66%CRLCharles River Laboratories International$342.81-0.9%Moderate Buy$308.17 -10.1%172.3911 of 5 starsAnalyst Forecast1.65%ALNYAlnylam Pharmaceuticals$159.85+5.4%Moderate Buy$305.86 91.3%264.8445 of 5 stars1.55%NBIXNeurocrine Biosciences$174.41+3.1%Moderate Buy$202.32 16.0%244.8576 of 5 stars1.45%ICLRIcon$199.70-2.4%Moderate Buy$213.76 7.0%203.3637 of 5 stars1.36%BNTXBioNTech$87.65+0.5%Moderate Buy$122.27 39.5%193.8385 of 5 starsAnalyst ForecastGap Up1.12%TECHBio-Techne$72.800.0%Hold$68.92 -5.3%172.3091 of 5 starsEarnings Report1.03%QGENQiagen$50.31-0.4%Hold$46.09 -8.4%153.9074 of 5 stars1.01%BMRNBioMarin Pharmaceutical$58.33+2.1%Moderate Buy$87.91 50.7%254.0357 of 5 stars1.00%TEMTempus AI$79.43-1.4%Hold$79.37 -0.1%221.6892 of 5 starsGap Down This page (NASDAQ:BBH) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersWatch This NowJensen Huang, the man who launched the AI boom, just called what Elon Musk is chasing "the final frontier of A...StocksToTrade | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredThis 10.3% war bond closed once. It's finally open again.Todd Phillips has spent 30 years studying safe-money income. His test for real retirement income: can it promi...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
